search button

Overexpression of cofilin 1 in prostate cancer and the corresponding clinical implications

  • Authors:
    • Li Lu
    • Ni Fu
    • Xu Luo
    • Xiao‑Yun Li
    • Xiao‑Ping Li

  • View Affiliations

  • Published online on: April 21, 2015     https://doi.org/10.3892/ol.2015.3133
  • Pages: 2757-2761
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cofilin 1 (CFL1) is a cytoskeletal protein and overexpression of the protein has been associated with aggressiveness in certain types of malignancies. The aim of the present study was to investigate the clinical implications of CFL1 expression in prostate cancer (PCa). Immunohistochemical analysis was performed using formalin‑fixed paraffin‑embedded tissue sections obtained from 111 patients with PCa and 47 patients with benign prostatic hyperplasia (BPH). In total, 78 (70.3%) out of 111 PCa tissues were found to express the CFL1 protein, while no expression was detected in BPH tissues. In addition, CFL1 was also observed to be significantly associated with the Gleason score (GS; <7 vs. ≥7; P<0.0001) and presence of lymph node metastasis (presence vs. absence; P<0.0001). However, there was no association between the expression of CFL1 and other clinicopathological variables, such as age (<69 years vs. ≥69 years; P=0.54), pre‑operative prostate specific antigen level (<20 ng/ml vs. ≥20 ng/ml; P=0.45) and pathological stage (T2 vs. ≥T3a; P=0.055). In addition, 35 tissues (31.5%) were observed to possess a CFL1‑positive mesenchyme. CFL1 expression was revealed to be an independent predictive factor for a high GS. The status of CFL1 expression in the mesenchyme also found to individually predict extraprostatic extension in PCa patients, based on multivariate analysis. The results of the present study indicated that CFL1 may specifically predict the development of PCa, and that the expression of CFL1 in the mesenchyme may be closely associated with the development of lymph node metastasis.
View Figures
View References

Related Articles

Journal Cover

June-2015
Volume 9 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Lu L, Fu N, Luo X, Li XY and Li XP: Overexpression of cofilin 1 in prostate cancer and the corresponding clinical implications. Oncol Lett 9: 2757-2761, 2015.
APA
Lu, L., Fu, N., Luo, X., Li, X., & Li, X. (2015). Overexpression of cofilin 1 in prostate cancer and the corresponding clinical implications. Oncology Letters, 9, 2757-2761. https://doi.org/10.3892/ol.2015.3133
MLA
Lu, L., Fu, N., Luo, X., Li, X., Li, X."Overexpression of cofilin 1 in prostate cancer and the corresponding clinical implications". Oncology Letters 9.6 (2015): 2757-2761.
Chicago
Lu, L., Fu, N., Luo, X., Li, X., Li, X."Overexpression of cofilin 1 in prostate cancer and the corresponding clinical implications". Oncology Letters 9, no. 6 (2015): 2757-2761. https://doi.org/10.3892/ol.2015.3133